APA (7th ed.) Citation

Gourzoulidis, G., Zisimopoulou, O., Boubouchairopoulou, N., Michailidi, C., Lowry, C., Tzanetakos, C., & Kourlaba, G. Cost-effectiveness Analysis of Lorlatinib in Patients Previously Treated with Anaplastic Lymphoma Kinase Inhibitors for Non-small Cell Lung Cancer in Greece. Columbia Data Analytics, LLC.

Chicago Style (17th ed.) Citation

Gourzoulidis, George, Oresteia Zisimopoulou, Nadia Boubouchairopoulou, Christina Michailidi, Chrissy Lowry, Charalampos Tzanetakos, and Georgia Kourlaba. Cost-effectiveness Analysis of Lorlatinib in Patients Previously Treated with Anaplastic Lymphoma Kinase Inhibitors for Non-small Cell Lung Cancer in Greece. Columbia Data Analytics, LLC.

MLA (9th ed.) Citation

Gourzoulidis, George, et al. Cost-effectiveness Analysis of Lorlatinib in Patients Previously Treated with Anaplastic Lymphoma Kinase Inhibitors for Non-small Cell Lung Cancer in Greece. Columbia Data Analytics, LLC.